Chikungunya: The silent threat in the shadows

Q3 Medicine
Ambreen Talib , Rabbya Rayan Shah , Rameen Atique , Hafiza Arshi Saeed , Ayesha Haidar , Ayesha Nadeem , Areesha Naveed , Javeria Sharif , Ayesha Muazzam , Abdul Samad
{"title":"Chikungunya: The silent threat in the shadows","authors":"Ambreen Talib ,&nbsp;Rabbya Rayan Shah ,&nbsp;Rameen Atique ,&nbsp;Hafiza Arshi Saeed ,&nbsp;Ayesha Haidar ,&nbsp;Ayesha Nadeem ,&nbsp;Areesha Naveed ,&nbsp;Javeria Sharif ,&nbsp;Ayesha Muazzam ,&nbsp;Abdul Samad","doi":"10.1016/j.clinmicnews.2025.02.001","DOIUrl":null,"url":null,"abstract":"<div><div>Chikungunya virus (CHIKV) is mostly related to arboviruses that cause serious public health threats. CHIKV belongs to the family <em>Togaviridae</em> and genus <em>Alphavirus, the cause of chikungunya</em> fever (CHIKF), an arthritogenic disease. Its distinguishing feature is intense arthralgia that lasts for months and even years in susceptible persons. CHIKF is a re-emerging disease that has occurred as an epidemic in Africa across Asia and America in recent decades and has caused global health threats, leading to outbreaks that impact millions of people. Pathogenesis of CHIKV has been researched for &gt;50 years, but no evidence has led to the development of vaccines or drugs. Current management involves reliving symptoms by supportive care to improve the quality of patients’ lives. The ongoing outbreaks of CHIKV show that there is a crying need to understand the pathogenesis of CHIKV. It is important to comprehend CHKIV to develop prevention and control measures for the spread of the disease. This review aims to provide comprehensive knowledge about CHIKV, shedding light on its host-related factors, vector-related factors, and complicated interactions of viral genetics. By following these complex interactions, this review aims to communicate the studies and research about CHIKV, offering strategies that lead to more effective prevention and control measures for this re-emerging global health threat.</div></div>","PeriodicalId":39211,"journal":{"name":"Clinical Microbiology Newsletter","volume":"51 ","pages":"Pages 1-14"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology Newsletter","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0196439925000054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Chikungunya virus (CHIKV) is mostly related to arboviruses that cause serious public health threats. CHIKV belongs to the family Togaviridae and genus Alphavirus, the cause of chikungunya fever (CHIKF), an arthritogenic disease. Its distinguishing feature is intense arthralgia that lasts for months and even years in susceptible persons. CHIKF is a re-emerging disease that has occurred as an epidemic in Africa across Asia and America in recent decades and has caused global health threats, leading to outbreaks that impact millions of people. Pathogenesis of CHIKV has been researched for >50 years, but no evidence has led to the development of vaccines or drugs. Current management involves reliving symptoms by supportive care to improve the quality of patients’ lives. The ongoing outbreaks of CHIKV show that there is a crying need to understand the pathogenesis of CHIKV. It is important to comprehend CHKIV to develop prevention and control measures for the spread of the disease. This review aims to provide comprehensive knowledge about CHIKV, shedding light on its host-related factors, vector-related factors, and complicated interactions of viral genetics. By following these complex interactions, this review aims to communicate the studies and research about CHIKV, offering strategies that lead to more effective prevention and control measures for this re-emerging global health threat.
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Microbiology Newsletter
Clinical Microbiology Newsletter Medicine-Infectious Diseases
CiteScore
2.20
自引率
0.00%
发文量
35
审稿时长
53 days
期刊介绍: Highly respected for its ability to keep pace with advances in this fast moving field, Clinical Microbiology Newsletter has quickly become a “benchmark” for anyone in the lab. Twice a month the newsletter reports on changes that affect your work, ranging from articles on new diagnostic techniques, to surveys of how readers handle blood cultures, to editorials questioning common procedures and suggesting new ones.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信